Wall Street Fundamentals Releases New In-Depth Stock Reports on ALNY, LJPC, NLNK and XOMA


Follow this company

Companies Mentioned

NASDAQ:ALNY / NASDAQ:LJPC / NASDAQ:NLNK / NASDAQ:XOMA
04/11/2014 [ACCESSWIRE]

U.S. markets were dragged lowered Thursday by a continued sell-off in the Biotech and Technology Sectors. The S&P 500 Index declined 2.09 percent to close at 1,833.08, while the Nasdaq Composite Index fell 3.10 percent, the most since 2011, to settle at 4,054.11. "There’s still a continual rotation out of the high-flying momentum stocks of 2013 into more value-driven opportunities," said Stifel Nicolaus portfolio manager Chad Morganlander. "This will continue in the coming weeks as investors look for consistency in earnings. You have concerns about high valuations and flat revenue growth, which is a perfect cocktail for a sector rotation out of growth and into value." Here is how some Biotech companies reacted Thursday:

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) shares traded in the range of $56.80 to $65.54 Thursday before settling to close at $57.92, a decrease of 12.11 percent. The stock appears to be facing some resistance at the $62.21 and $66.91 levels with some support at $56.58 and $50.79. Shares of Alnylam Pharmaceuticals have fallen approximately 10.0 percent year-to-date.

More information on Alnylam Pharmaceuticals and access to the free equity report can be found at: 
www.WallStreetFundamentals.com/ALNY

La Jolla Pharmaceutical Company (NASDAQ: LJPC) shares traded in the range of $10.09 to $11.18 Thursday before settling to close at $10.24, a decrease of 9.14 percent. The stock appears to be facing some resistance at the $11.29 and $13.55 levels with some support at $9.87 and $9.37. Shares of La Jolla Pharmaceutical are up approximately 40.0 percent year-to-date.

More information on La Jolla Pharmaceutical and access to the free equity report can be found at: 
www.WallStreetFundamentals.com/LJPC

NewLink Genetics Corp. (NASDAQ: NLNK) shares traded in the range of $22.39 to $25.21 Thursday before settling to close at $22.51, a decrease of 11.69 percent. The stock appears to be facing some resistance at the $23.42 and $27.79 levels with some support at $21.09 and $18.45. Shares of NewLink Genetics are up approximately 2.0 percent year-to-date.

More information on NewLink Genetics and access to the free equity report can be found at:      
www.WallStreetFundamentals.com/NLNK

XOMA Corp. (NASDAQ: XOMA) shares traded in the range of $4.28 to $4.80 Thursday before settling to close at $4.30, a decrease of 9.28 percent. The stock appears to be facing some resistance at the $3.77 and $5.27 levels with some support at $3.81. Shares of Regado Biosciences have fallen approximately 30.0 percent year-to-date.

More information on XOMA and access to the free equity report can be found at: 
www.WallStreetFundamentals.com/XOMA

Wall Street Fundamentals offers our members a full range of investor services including in-depth equity reports on your favorite companies and timely market updates featuring the hottest stocks trending in the marketplace.

Activate your always free membership by signing up at www.WallStreetFundamentals.com today.

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Wall Street Fundamentals has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Wall Street Fundamentals
Website: www.WallStreetFundamentals.com
Email: editor@wallstreetfundamentals.com

COMMENTS

Leave a comment...
 * 

Your Name
 *